Earnings History Data for Sonnet BioTherapeutics Holdings, Inc. (SONN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-05-2023 | PM | SONN | Sonnet BioTherapeutics Holdings, Inc. | 4.90 | -0.34 | 0.00 | -1.96 | Sonnet BioTherapeutics GAAP EPS of -$0.34, revenue of $36.45M [5/10/2023 9:08 AM] |
0.2295 | -0.01 (-3.57%) |
0.24 | 0.0 (0.84%) |
0.20 - 4.56 | 1,757,326 | 1,510,000 | 144,682 | ||
| 13-02-2023 | PM | SONN | Sonnet BioTherapeutics Holdings, Inc. | 7.67 | -0.80 | 0.00 | -1.40 | Sonnet BioTherapeutics GAAP EPS of -$0.80 beats by $0.30, revenue of $0.04M misses by $0.06M [2/13/2023 8:58 AM] |
0.92 | -0.02 (-2.13%) |
0.93 | -0.01 (-1.17%) |
0.91 - 9.37 | 114,541 | 320,000 | 6,049 | ||
| 17-05-2021 | PM | SONN | Sonnet BioTherapeutics Holdings, Inc. | 25.63 | -0.32 | 0.00 | -0.05 | Sonnet BioTherapeutics reports FQ2 results [5/17/2021 7:30 AM] |
1.65 | 0.07 (4.43%) |
1.53 | -0.05 (-3.16%) |
1.44 - 7.89 | 548,323 | 2,700,000 | 1,559 | ||